CTKB
Cytek Biosciences, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$5.88
−1.34%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 3.44x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.37x
- Price / sales
- 3.70x
- Price / cash flow
- -126.58x
Enterprise value
- Enterprise value
- $528.8M
- EV / sales
- 2.56x
- EV / EBITDA
- -19.47x
- EV / EBIT
- -11.84x
- Market cap
- $764.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026